Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:3139-3142
Published online before print July 23, 2009, doi: 10.1161/STROKEAHA.109.549774
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/9/3139    most recent
STROKEAHA.109.549774v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jadhav, V.
Right arrow Articles by Zhang, J. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jadhav, V.
Right arrow Articles by Zhang, J. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Traumatic Brain Injury
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Acute Cerebral Infarction

(Stroke. 2009;40:3139.)
© 2009 American Heart Association, Inc.


Research Letters

Cyclo-Oxygenase-2 Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection in the Mouse Model of Surgical Brain Injury

Vikram Jadhav, MD, PhD; Robert P. Ostrowski, MD, PhD; Wenni Tong, BS; Brenden Matus; Rachel Jesunathadas, BS John H. Zhang, MD, PhD

From the Departments of Physiology and Pharmacology (V.J., R.P.O., W.T., B.M., R.J., J.H.Z.), Neurosurgery (J.H.Z.), and Anesthesiology (J.H.Z.), Loma Linda University, School of Medicine, Loma Linda, Calif.

Correspondence to John H. Zhang, MD, PhD, Department of Neurosurgery, Loma Linda University Medical Center, 11234 Anderson Street, Room 2562B, Loma Linda, CA 92350. E-mail johnzhang3910{at}yahoo.com

Background and Purpose— We investigated the role of cyclo-oxygenase-2 (COX-2) in mechanisms of hyperbaric oxygen preconditioning (HBO-PC) in the mouse model of surgical brain injury (SBI).

Methods— C57BL mice were administered 100% oxygen for 1 hour at 2.5 atmosphere absolute for 5 consecutive days and subjected to SBI. Neurological status and brain edema were evaluated at 24 hours and 72 hours after the brain insult. Fluorescent immunostaining and Western blotting were performed to study hypoxia-inducible factor-1{alpha} and COX-2, respectively. Two doses of COX-2 inhibitor, NS398 (3 mg/kg and 10 mg/kg) were used to verify the role of COX-2 signaling pathway in the mechanism of HBO-PC.

Results— HBO-PC improved neurological status and decreased brain edema at 24 hours and 72 hours after SBI. HBO-PC by itself and SBI independently increased COX-2 levels by 2-fold and 4-fold, respectively. HBO-PC, however, reduced increase in hypoxia-inducible factor-1{alpha} and COX-2 expression after SBI. The HBO-PC-induced improvement in neurological status and brain edema was reversed by a suboptimal dose of the COX-2 inhibitor, NS398 (10 mg/kg intraperitoneally; 1/4th of dose shown to provide neuroprotection), which itself had no effect on investigated end points.

Conclusions— HBO-PC attenuates postoperative brain edema and improves neurological outcomes after SBI. The HBO-PC-induced neuroprotection is mediated through COX-2 signaling pathways.


Key Words: brain edema • brain injury • cyclo-oxygenase-2 • hyperbaric oxygen • preconditioning • surgical neuroprotection